Loading...

Piramal Pharma Limited Rights Issue (Piramal Pharma Rights Issue 2023) Detail

Piramal Pharma Limited Logo

Incorporated in 2020, Piramal Pharma Limited a flagship company of Piramal Group offers pharmaceutical products and services across a domestic and global distribution network.

The company has 15 global manufacturing facilities and a global distribution network in over 100 countries.

Piramal Pharma includes:

  1. Piramal Pharma Solutions (PPS), is an integrated Contract Development and Manufacturing Organization (CDMO). It develops and manufactures solutions through a globally integrated network of facilities across the drug life cycle to innovators and generic companies.
  2. Piramal Critical Care (PCC), is a Complex Hospital Generics business whose product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain and anesthetics, injectable anti-infectives, and other therapies.
  3. India Consumer Healthcare (ICH) business, selling over-the-counter products.

Piramal Pharma Rights Issue 2023 Detail

Issue Open
Security Name Piramal Pharma Limited
Issue Size (Shares) [.]
Issue Size (Amount) ₹1,050.00 Crores
Issue Price
Face Value ₹10 per share
Listing At BSE, NSE
Terms of Payment
Entitlement

Company Financials

Piramal Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-217,251.086,479.01835.035,076.752,910.19
31-Mar-228,729.826,834.90375.966,069.944,023.28
Amount in ₹ Crore

Objects of the Issue:

The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
1. Repayment or prepayment, in full or in part, of certain borrowings.
2. General corporate purposes.

Piramal Pharma Rights Issue 2023 Documents

Piramal Pharma Rights Issue 2023 Rating

11
1.7
Rating:Rated 1.7 stars
Vote Here ...

Piramal Pharma Rights Issue 2023 Reviews

Sorry, we couldn't find any reviews, please check back later.

Company Contact Information

Piramal Pharma Limited
Ground Floor, Piramal Ananta,
Agastya Corporate Park, Kamani Junction,
LBS Marg, Kurla, Mumbai 400 070

Phone: +91 22 3802 3000
Email: shareholders.ppl@piramal.com
Website: https://www.piramal.com/

Piramal Pharma Rights Issue 2023 Registrar

  1. Link Intime India Private Ltd
    Phone: +91-22-4918 6270
    Email: ppl.rights@linkintime.co.in
    Website: https://linkintime.co.in/

Piramal Pharma Rights Issue 2023 Lead Manager(s)

Find Piramal Pharma Rights Issue 2023 Latest Update

Piramal Pharma Rights Issue 2023 FAQs

The Piramal Pharma Rights Issue 2023 open and close dates are not available as of now.

Sorry the Piramal Pharma Rights Issue 2023 timelines are not available at this time.

The price of the Piramal Pharma Rights Issue 2023 is not yet set.

The Piramal Pharma Rights Issue 2023 ratio is not yet declared.

The Piramal Pharma Rights Issue 2023 record date is not yet declared.

The issue size of Piramal Pharma Rights Issue 2023 is of [.] equity shares at aggregating upto ₹1,050.00 Crores.

The Letter of Offer for Piramal Pharma Rights Issue 2023 can be download here.

You can apply for Piramal Pharma Rights Issue 2023 in two ways:

  1. Net Banking (ASBA)
  2. Registrar's Website (R-WAP Facility)

Steps to apply for Piramal Pharma Rights Issue 2023 using Net Banking (ASBA)

  1. Log in to the net banking account of your bank.
  2. Go to the 'IPO & Rights Issue' section.
  3. Check if the Piramal Pharma Rights Issue 2023 available on the list.
  4. Click the Apply button next to the Piramal Pharma Rights Issue 2023.
  5. Fill and check your information.
  6. Submit the application.

Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.

Steps to apply for Piramal Pharma Rights Issue 2023 using Registrar's website (R-WAP)

  1. Visit registrar's website
  2. Go to the 'Rights Issue' section
  3. Select Piramal Pharma Rights Issue 2023 from the dropdown.
  4. Enter Demat Account Number.
  5. Fill the online application form.
  6. Validate and submit the application.

1 Comments

1. Pbdrajkot   I Like It. |Report Abuse|  Link|Apr 12, 2023 3:46:26 PMReply
Any news for price and date ?

Compare rights issues with Piramal Pharma Rights Issue 2023